Flagship Pioneering as of June 30, 2019
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 10 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 37.3 | $861M | 59M | 14.64 | |
| Rubius Therapeutics | 26.1 | $602M | 38M | 15.73 | |
| Kaleido Biosciences Ord (KLDO) | 8.7 | $201M | 17M | 11.60 | |
| Denali Therapeutics (DNLI) | 7.2 | $166M | 8.0M | 20.76 | |
| Evelo Biosciences | 7.1 | $164M | 18M | 8.98 | |
| Axcella Health Inc equity | 3.5 | $81M | 8.7M | 9.31 | |
| Transmedics Group (TMDX) | 3.2 | $73M | 2.5M | 28.99 | |
| Seres Therapeutics | 3.0 | $70M | 22M | 3.22 | |
| Quanterix Ord (QTRX) | 2.7 | $62M | 1.8M | 33.79 | |
| Syros Pharmaceuticals | 1.3 | $30M | 3.2M | 9.26 |
